| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 5e-06 |